| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.031 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |